According to ArriVent BioPharma's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โฌ80.23 Million a decrease over its 2023 earnings that were of -โฌ63.46 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.